HEALTHCARE
Global Veterinary Therapeutics Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Veterinary Therapeutics Market, By Type (Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others), Product Type (Drugs, Vaccines, Medicated Feed Additives), Animal Type (Companion Animal, Livestock Animal), Route of Administration (Oral, Parenteral, Topical), Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others), Application (Pets, Cattle, Poultry, Swine, Others), Drug stores (Veterinary clinics, Veterinary hospitals, Pharmacies), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global Veterinary Therapeutics market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Veterinarian therapeutics is the area of veterinary medicine that focuses on using medications, vaccinations, and medical equipment to treat illnesses and ailments in animals. It includes the identification, avoidance, and management of diseases in a variety of animal species, including exotics, pets, and livestock. Veterinary therapies seek to improve animal health, welfare, and production, benefiting both individual animals and larger populations. The veterinary therapeutics market includes the manufacture, distribution, and sale of medicines, vaccines, and medical equipment created exclusively for animal use. It covers both therapeutic and preventive methods, with a broad selection of goods catered to various animal species and health situations. Advancements in veterinary medicine, regulatory frameworks, animal disease outbreaks, and rising demand for companion animal healthcare all have an impact on the industry.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Growing pet ownership and spending on animal health.
- Increasing awareness about animal health.
RESTRAINTS
- High cost of veterinary medicines.
- Stringent regulations for drug approval.
OPPORTUNITIES
- Expansion in emerging markets.
- Development of novel therapeutics.
CHALLENGES
- Resistance to antimicrobial agents.
- Lack of skilled veterinarians.
SEGMENTATION
- Type
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Analgesics
- Sedatives
- Others
- Product Type
- Drugs
- Vaccines
- Medicated Feed Additives
- Animal Type
- Companion Animal
- Livestock Animal
- Route of Administration
- Oral
- Parenteral
- Topical
- Distribution Channels
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
- Application
- Pets
- Cattle
- Poultry
- Swine
- Others
- End-user
- Drug stores
- Veterinary clinics
- Veterinary hospitals
- Pharmacies
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Zoetis
- Intervet Inc. (Merck Animal Health)
- Elanco
- Merial
- Bayer AG
- Boehringer Ingelheim International GmbH
- Ceva
- Vetoquinol S.A.
- IDEXX Laboratories, Inc.
- Virbac
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Veterinary Therapeutics Market, by Type
- 3.2 Global Veterinary Therapeutics Market, by Product Type
- 3.3 Global Veterinary Therapeutics Market, by Animal Type
- 3.4 Global Veterinary Therapeutics Market, by Route of Administration
- 3.5 Global Veterinary Therapeutics Market, by Distribution Channels
- 3.6 Global Veterinary Therapeutics Market, by Application
- 3.7 Global Veterinary Therapeutics Market, by Drug stores
- 3.8 Global Veterinary Therapeutics Market, by Geography
- 3.9 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Increasing adoption of companion animals.
- 5.1.2 Technological advancements in veterinary therapeutics.
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Growing pet ownership and spending on animal health.
- 5.2.2 Increasing awareness about animal health.
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High cost of veterinary medicines.
- 5.3.2 Stringent regulations for drug approval.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Expansion in emerging markets.
- 5.4.2 Development of novel therapeutics.
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Resistance to antimicrobial agents.
- 5.5.2 Lack of skilled veterinarians.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY TYPE
- 6.1 Type Summary
- 6.2 Market Attractive Index
- 6.3 Global Veterinary Therapeutics Market, by Type (2019-2032)
- SECTION 7 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY PRODUCT TYPE
- 7.1 Product Type Summary
- 7.2 Market Attractive Index
- 7.3 Global Veterinary Therapeutics Market, by Product Type (2019-2032)
- SECTION 8 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY ANIMAL TYPE
- 8.1 Animal Type Summary
- 8.2 Market Attractive Index
- 8.3 Global Veterinary Therapeutics Market, by Animal Type (2019-2032)
- SECTION 9 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION
- 9.1 Route of Administration Summary
- 9.2 Market Attractive Index
- 9.3 Global Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- SECTION 10 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY DISTRIBUTION CHANNELS
- 10.1 Distribution Channels Summary
- 10.2 Market Attractive Index
- 10.3 Global Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- SECTION 11 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY APPLICATION
- 11.1 Application Summary
- 11.2 Market Attractive Index
- 11.3 Global Veterinary Therapeutics Market, by Application (2019-2032)
- SECTION 12 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY DRUG STORES
- 12.1 Drug stores Summary
- 12.2 Market Attractive Index
- 12.3 Global Veterinary Therapeutics Market, by Drug stores (2019-2032)
- SECTION 13 - GLOBAL VETERINARY THERAPEUTICS MARKET, BY GEOGRAPHY
- 13.1 Regional Summary
- 13.2 Market Attractive Index
- 13.3 Global Veterinary Therapeutics Market, by Geography (2019-2032)
- SECTION 14 - NORTH AMERICA VETERINARY THERAPEUTICS MARKET
- 14.1 North America Summary
- 14.2 Market Attractive Index
- 14.3 North America Veterinary Therapeutics Market, by Type (2019-2032)
- 14.4 North America Veterinary Therapeutics Market, by Product Type (2019-2032)
- 14.5 North America Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 14.6 North America Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 14.7 North America Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 14.8 North America Veterinary Therapeutics Market, by Application (2019-2032)
- 14.9 North America Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 14.10 North America Veterinary Therapeutics Market, by Country (2019-2032)
- 14.10.1 U.S.
- 14.10.2 Canada
- 14.10.3 Mexico
- 14.10.4 Rest of North America
- SECTION 15 - EUROPE VETERINARY THERAPEUTICS MARKET
- 15.1 Europe Summary
- 15.2 Market Attractive Index
- 15.3 Europe Veterinary Therapeutics Market, by Type (2019-2032)
- 15.4 Europe Veterinary Therapeutics Market, by Product Type (2019-2032)
- 15.5 Europe Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 15.6 Europe Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 15.7 Europe Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 15.8 Europe Veterinary Therapeutics Market, by Application (2019-2032)
- 15.9 Europe Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 15.10 Europe Veterinary Therapeutics Market, by Country (2019-2032)
- 15.10.1 Germany
- 15.10.2 U.K.
- 15.10.3 France
- 15.10.4 Italy
- 15.10.5 Spain
- 15.10.6 Russia
- 15.10.7 The Netherlands
- 15.10.8 Belgium
- 15.10.9 Turkey
- 15.10.10 Rest of Europe
- SECTION 16 - ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET
- 16.1 Asia-Pacific Summary
- 16.2 Market Attractive Index
- 16.3 Asia-Pacific Veterinary Therapeutics Market, by Type (2019-2032)
- 16.4 Asia-Pacific Veterinary Therapeutics Market, by Product Type (2019-2032)
- 16.5 Asia-Pacific Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 16.6 Asia-Pacific Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 16.7 Asia-Pacific Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 16.8 Asia-Pacific Veterinary Therapeutics Market, by Application (2019-2032)
- 16.9 Asia-Pacific Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 16.10 Asia-Pacific Veterinary Therapeutics Market, by Country (2019-2032)
- 16.10.1 China
- 16.10.2 India
- 16.10.3 Japan
- 16.10.4 South Korea
- 16.10.5 Singapore
- 16.10.6 Malaysia
- 16.10.7 Australia
- 16.10.8 Thailand
- 16.10.9 Philippines
- 16.10.10 Rest of Asia-Pacific
- SECTION 17 - SOUTH AMERICA VETERINARY THERAPEUTICS MARKET
- 17.1 South America Summary
- 17.2 Market Attractive Index
- 17.3 South America Veterinary Therapeutics Market, by Type (2019-2032)
- 17.4 South America Veterinary Therapeutics Market, by Product Type (2019-2032)
- 17.5 South America Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 17.6 South America Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 17.7 South America Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 17.8 South America Veterinary Therapeutics Market, by Application (2019-2032)
- 17.9 South America Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 17.10 South America Veterinary Therapeutics Market, by Country (2019-2032)
- 17.10.1 Brazil
- 17.10.2 Argentina
- 17.10.3 Chile
- 17.10.4 Colombia
- 17.10.5 Rest of South America
- SECTION 18 - MIDDLE EAST AND AFRICA VETERINARY THERAPEUTICS MARKET
- 18.1 Middle East and Africa Summary
- 18.2 Market Attractive Index
- 18.3 Middle East and Africa Veterinary Therapeutics Market, by Type (2019-2032)
- 18.4 Middle East and Africa Veterinary Therapeutics Market, by Product Type (2019-2032)
- 18.5 Middle East and Africa Veterinary Therapeutics Market, by Animal Type (2019-2032)
- 18.6 Middle East and Africa Veterinary Therapeutics Market, by Route of Administration (2019-2032)
- 18.7 Middle East and Africa Veterinary Therapeutics Market, by Distribution Channels (2019-2032)
- 18.8 Middle East and Africa Veterinary Therapeutics Market, by Application (2019-2032)
- 18.9 Middle East and Africa Veterinary Therapeutics Market, by Drug stores (2019-2032)
- 18.10 Middle East and Africa Veterinary Therapeutics Market, by Country (2019-2032)
- 18.10.1 Kingdom of Saudi Arabia
- 18.10.2 South Africa
- 18.10.3 U.A.E.
- 18.10.4 Egypt
- 18.10.5 Rest of Middle East and Africa
- SECTION 19 - COMPANY SHARE ANALYSIS
- 19.1 Global Veterinary Therapeutics Market, Company Share Analysis
- 19.2 North America Veterinary Therapeutics Market, Company Share Analysis
- 19.3 Europe Veterinary Therapeutics Market, Company Share Analysis
- 19.4 Asia-Pacific Veterinary Therapeutics Market, Company Share Analysis
- SECTION 20 - COMPANY PROFILES
- 20.1 Zoetis
- 20.1.1 Company Snapshot
- 20.1.2 Financial Overview
- 20.1.3 Product Portfolio
- 20.1.4 Recent Developments
- 20.2 Intervet Inc. (Merck Animal Health)
- 20.2.1 Company Snapshot
- 20.2.2 Financial Overview
- 20.2.3 Product Portfolio
- 20.2.4 Recent Developments
- 20.3 Elanco
- 20.3.1 Company Snapshot
- 20.3.2 Financial Overview
- 20.3.3 Product Portfolio
- 20.3.4 Recent Developments
- 20.4 Merial
- 20.4.1 Company Snapshot
- 20.4.2 Financial Overview
- 20.4.3 Product Portfolio
- 20.4.4 Recent Developments
- 20.5 Bayer AG
- 20.5.1 Company Snapshot
- 20.5.2 Financial Overview
- 20.5.3 Product Portfolio
- 20.5.4 Recent Developments
- 20.6 Boehringer Ingelheim International GmbH
- 20.6.1 Company Snapshot
- 20.6.2 Financial Overview
- 20.6.3 Product Portfolio
- 20.6.4 Recent Developments
- 20.7 Ceva
- 20.7.1 Company Snapshot
- 20.7.2 Financial Overview
- 20.7.3 Product Portfolio
- 20.7.4 Recent Developments
- 20.8 Vetoquinol S.A.
- 20.8.1 Company Snapshot
- 20.8.2 Financial Overview
- 20.8.3 Product Portfolio
- 20.8.4 Recent Developments
- 20.9 IDEXX Laboratories, Inc.
- 20.9.1 Company Snapshot
- 20.9.2 Financial Overview
- 20.9.3 Product Portfolio
- 20.9.4 Recent Developments
- 20.10 Virbac
- 20.10.1 Company Snapshot
- 20.10.2 Financial Overview
- 20.10.3 Product Portfolio
- 20.10.4 Recent Developments
- SECTION 21 - RELATED REPORTS
- SECTION 22 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.